Filter
438
Filtered Results: 438
Text search:
Revised
National
TB
Control
Programme,
India
Featured
Recommendations
46
New Publications
164
Language
Document type
No document type
312
Guidelines
44
Studies & Reports
43
Manuals
19
Strategic & Response Plan
10
Situation Updates
5
Training Material
4
Resource Platforms
1
Countries / Regions
India
106
Nepal
23
Myanmar / Burma
17
Global
11
South Africa
9
Bangladesh
9
Nigeria
8
South–East Asia Region
8
Malawi
7
Uganda
6
Indonesia
5
Sierra Leone
4
Kenya
4
Western and Central Europe
4
Asia
4
Pakistan
3
Mozambique
3
Africa
3
Congo, Democratic Republic of
2
Ethiopia
2
Zimbabwe
2
Philippines
2
Zambia
2
Tanzania
2
Cambodia
2
Thailand
2
Botswana
2
Sri Lanka
2
East and Southern Africa
2
Latin America and the Carribbean
2
Bhutan
2
Timor Leste/ East Timor
2
Guinea
1
Liberia
1
Senegal
1
Afghanistan
1
Syria
1
Rwanda
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Namibia
1
Lesotho
1
Yemen
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Eastern Europe
1
North Korea
1
Laos
1
Russia
1
Vietnam
1
North America
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
189
Clinical Guidelines
56
Women & Child Health
19
Public Health
17
Key Resources
6
Pharmacy & Technologies
6
Capacity Building
4
Toolboxes
TB
93
HIV
61
AMR
16
Global Health Education
11
COVID-19
10
Caregiver
10
Disability
8
Refugee
7
NTDs
7
Polio
6
Mental Health
6
Ebola
4
Rapid Response
4
Health Financing Toolbox
4
Planetary Health
3
Pharmacy
3
Conflict
2
Natural Hazards
2
Cholera
1
Specific Hazards
1
NCDs
1
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integr...
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the...
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast canc...
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients an...
A Step-by-Step Guide.
It is intended for health planners, dengue or vector control programme managers and individuals, nongovernmental organizations (NGOs) and other agencies with interests and/or ...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major components and features of effective systems for the tre...
For the Assesor's Guide Vol 1 and 2 see: nrhm.gov.in/images/pdf/programmes/maternal-health/guidelines/Operational_Guidelines_for_Quality_Assurance_in_Public_Health_Facilities_and_checklists-3_books.zip
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended...
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes... have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support (EMM)1 to help patients complete treatment and health-care workers to monitor both daily dosing and treatment continuity
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent ... in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); and advance integration within general child health services, including maternal and child health/ reproductive, maternal, newborn, child and adolescent health, HIV, nutrition and other programmes.
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB...
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are prov...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Th...
This document is intended for a wide audience including national and local policymakers, implementers and managers of national and local maternal and child health ..., non-governmental and other organizations and professional societies involved in the planning and management of maternal and child health services, health professionals including obstetricians, midwives, nurses, general medical practitioners, academic staff involved in training health professionals, managers of maternal and child health programmes and public health policymakers in all settings.
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combi...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized contro...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the ... level highlighted in this fourth GLASS report.
The fourth GLASS report summarizes the 2019 data reported to WHO in 2020. It includes data on AMC surveillance from 15 countries and AMR data on 3 106 602 laboratory-confirmed infections reported by 24 803 surveillance sites in 70 countries, compared to the 507 923 infections and 729 surveillance sites reporting to the first data call in 2017.
The report also describes developments over the past years of GLASS and other AMR surveillance programmes led by WHO, including resistance to anti-human immunodeficiency virus and anti-tuberculosis medicines, antimalarial drug efficacy.
